Cardiac‐specific down‐regulation of carnitine palmitoyltransferase‐1b (CPT‐1b) prevents cardiac remodeling in obese mice
Obesity2016Vol. 24(12), pp. 2533–2543
Citations Over TimeTop 24% of 2016 papers
Yijie Zhang, Xian-Long Fang, Mingyan Dai, Quan Cao, Tuantuan Tan, Wenbo He, Yan Huang, Liang Chu, Mingwei Bao
Abstract
Cardiac CPT-1b suppression protects against the aggravation of cardiac morphology and function associated with HFD feeding. CPT-1b represents a potential therapeutic target for the treatment of cardiac dysfunction related to metabolic diseases such as obesity and diabetes.
Related Papers
- → 2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway(2022)9 cited
- → Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis(2017)7 cited
- → L-Propionylcarnitine effects on cardiac carnitine content and function in secondary carnitine deficiency(1995)10 cited
- Effects of L-carnitine on plasma free carnitine levels and cardiac functions in children with cardiomyopathy(2014)
- Effect of L-carnitine in treatment of chronic heart failure(2009)